Umeclidinium bromide
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Umeclidinium bromide, covering 2014-04-16 to 2025-08-27. Get the full timeline:
Most recent: EMA Authorised: Laventair Ellipta (previously Laventair) (umeclidinium bromide;vilanterol) — GlaxoSmithKline Trading Services Limited